Chapter 52
Chromosomes: Structure, Function, and Clinical Syndromes
BRIAN J.R. FORBES and LEONARD B. NELSON
Main Menu   Table Of Contents

Search

GENE DOSE EFFECTS IN CHROMOSOMAL ABNORMALITIES
MECHANISMS IN OCULAR CHROMOSOMAL DISEASE
A HISTORY OF HUMAN CYTOGENETICS
INCIDENCE OF CHROMOSOMAL ABNORMALITIES
CHROMOSOMAL SYNDROMES
HUMAN CHROMOSOME MAPPING: CLINICAL IMPLICATIONS
REFERENCES

Sanger's demonstration in 1953 that proteins are unique linear arrays of amino acids and the suggestion by Watson and Crick in that same year that DNA, the genetic material, is similarly a linear array of bases gradually led to the realization that genes are expressed by the linear translation of the base sequence of nucleic acids into the amino acid sequence of proteins. The genetic code is simply the sequence relationship between bases in genes and the amino acids they encode. The entire genetic blueprint of humans is composed of linear double-helix deoxyribonucleic acid (DNA) and is present in the 46 chromosomes of every human nucleated cell. Each species has a characteristic number of chromosomes. The functional unit of the genetic blueprint is the gene, a segment of DNA required to code for one polypeptide. The human genome was previously believed to contain approximately 100,000 distinct genes, however, the Human Genome Project reported that value as being closer to 30,000.1

The disorders discussed in this chapter are the result of loss, duplication, or rearrangement of whole groups of adjacent genes. As a result, patients show generalized and widespread systemic abnormalities, depending on the number and relative importance of the genes lost or duplicated. The chromosomal disorders may involve the entire genome resulting in triploidy or polyploidy or the disorders may be numerical resulting in monosomies and trisomies. Even with the latest banding techniques, the smallest detectable deletion or duplication of a single chromosome contains many genes.

The common dominant, recessive, or X-linked genetic disorders are the result of single-gene defects. Although generalized abnormalities are frequently present, they are caused by the effect of that single-gene product on many different aspects of development. Detection requires molecular techniques because the single-gene defects are not visible by cytogenetic techniques. Chromosomal disorders may be inherited in a dominant manner, but their generalized abnormalities are the result of multiple-gene imbalances and their generalized defects are often so severe that affected individuals often do not reproduce.

Back to Top
GENE DOSE EFFECTS IN CHROMOSOMAL ABNORMALITIES
The 46 chromosomes exist in 23 homologous pairs in the normal individual; one chromosome of each pair is from the mother, the other is from the father and one of each pair is transmitted to each child. Twenty-two pairs of chromosomes are alike in males and females and are, hence, called the autosomes; the two sex chromosomes, the remaining pair, differ in males and females. The members of the homologous pair carry the same genetic information; they have the same gene loci in the same sequence, although at any one locus they may have either the same or different alleles. Each of the human genes is, therefore, paired, and the total expression of any particular gene is the sum of the products coded for by both the maternal and paternal copies, or alleles, of that gene. Chromosomal abnormalities will, as a rule, involve only one of the two chromosomes in any pair. When a chromosome or part of chromosome is missing, the impaired alleles on the other chromosomes are expressed without modification. In the case of genes that code for enzymatic proteins, total activity will be reduced by 50% if the enzyme activity is gene dose dependent. On the other hand, when an entire chromosome or a position of one is duplicated, the genes in that segment have three alleles, and the gene product is present in 150% of normal amounts.

The abnormal dose effect of multiple genes in chromosomal disorders may have widespread effects on the developing organism. In Drosophila, mutations or deletions involving as many as 41 loci on all four chromosomes produced a similar phenotype consisting of slow development, small body size, large rough eyes, thin wings, and low fertility. These 41 loci represent sites of synthesis of transfer DNA, deficiency of which results in a generalized decreased rate of protein synthesis.2 Many of the human chromosomal abnormalities share common features: mental retardation, low fertility, growth retardation, and coarse and abnormal facial features, among others. In humans, as in Drosophila, the recurrent and overlapping phenotypes seen with many of the chromosomal abnormalities can be explained on the basis of a generalized decreased rate of protein synthesis.

Back to Top
MECHANISMS IN OCULAR CHROMOSOMAL DISEASE
Table 1, which summarizes the ocular features of some of the partial trisomies and partial deletion chromosomal syndromes, demonstrates the considerable phenotypic overlap among the various chromosomal disorders. It is believed that abnormal rates of cell division at critical times in embryogenesis, likely the result of abnormal gene dose effect, result in the generalized growth retardation and the congenital anomalies noted at birth.2 For example, closure of the fetal choroidal fissure takes place between the fifth and seventh week of gestation. If an embryo has an abnormal karyotype that causes retardation of localized cell division, the result may be that closure of the fetal choroidal fissure will not occur. Uveal coloboma is a feature of chromosomal disorders involving many different chromosomes.

 

Table 1. Ocular Signs in Partial Trisomy and Partial Deletion Chromosomal Syndromes


Ocular Signs by RegionOcular Signs by RegionOcular Signs by Region
OrbitAntimongoloid lid slantMotility
Hypertelorism4p-Nystagmus
3q+4p+11p+
4p-Trisomy 818q-
5p+9p+Strabismus
5p-10q+4p-
7q+11p+7q+
Trisomy 811q-Trisomy 8
10q-14q +9p-
10q+18p -11p+
11p+Ptosis18p-
11q-4p-18q-
13 ring10q+20p +
13q-18p-Anterior Segment
18p-Epicanthal foldsCorneal leukoma
18q-3q+4q+
Hypotelorism4p-Trisomy 8
14q+5p-Ectopia pupillae
18p-6p-9p+
Flat supraorbital ridges6q-Uveal Tract
11p+9p-Coloboma
Globe11q-4p+
Exophthalmos13q-4p-
4p-17p-6p-
Microphthalmia18p-Trisomy 8
Trisomy 818q-10p+
10 p+Telecanthus13q-
10q+5p+18q-
13q-9p+Optic Nerve
14q+20p+Optic atrophy
16q +Blepharophimosis18q-
Lids and Brows4p+Optic pit
Mongoloid lid slant10q+9p-
9p-14q+Retina
10p+Tear deficiencyPigmentary degeneration
11q-5p-5p-
18p-  
20p+  

 

Many of the ocular abnormalities noted in the chromosomal disorders are not chromosome specific; rather, they are secondary phenotypes. Orbital hypotelorism is found in many chromosomal disorders. In trisomy 21, the abnormally narrow space between the orbits is a result of primary hypoplasia of the central facial structures, whereas in the 13q+ and the 18p- syndromes the hypotelorism is associated with some degree of holoprosencephaly and trigonocephaly. In both situations, however, the end result is a phenotypic anomaly that results secondarily from a more basic defect in development as well. The ocular pathology in embryos with chromosomal abnormalities demonstrated that not only does retardation of development occur but also that various forms of dysgenesis of ocular structures occur. Specific findings included microphthalmia, cataract, subluxation of the lens, staphyloma of the optic nerve, retinal dysplasia, and cyclopia.3

Microphthalmia is an ocular abnormality seen in several chromosomal syndromes. The microphthalmia in trisomy 13 is probably related to the presence of holoprosencephaly. However, because microphthalmia is seen in other syndromes in which holoprosencephaly is not present, the defect must be nonspecific or related to some other specific gene locus. It is known, for example, that mutations on all four chromosomes of Drosophilia may produce small eyes or anophthalmia. In the mouse, genes on three separate chromosomes may result in the same ocular anomalies. Deletion or duplication of different portions of the human karyotype can result in microphthalmia. Hypertelorism, antimongoloid lid slant, epicanthal folds, highly arched eyebrows, strabismus, and colobomas are abnormalities that are frequently found among the chromosomal disorders (see Table 1).

Back to Top
A HISTORY OF HUMAN CYTOGENETICS
Before 1956 there were believed to be 48 human chromosomes; however, in that year Tjio and Levan4 showed that 46 was the correct number. In 1979, Hsu published a book reviewing the history of human cytogenetics in which he divided the subject into four eras: the dark ages before 1952, the hypotonic period from 1952 to 1958, the trisomy period between 1959 and 1969, and the current chromosome banding era that started in 1970.

In the dark ages, Painter, in 1923, was studying slides of paraffin-sectioned testes and suggested 48 as the number of chromosomes in humans. Because his paper was cited repeatedly that number was eventually repeated as fact. During this era, the squash technique for separating human metaphase chromosomes was developed, and the chemical prefixation technique and the use of colchicine to block cell division metaphase were also introduced. In 1952, Hsu introduced the hypotonic technique, which leads to control of swelling of the cells and separation of individual chromosomes. It was this technique that allowed Tjio and Levan to determine the correct number of human chromosomes. The techniques introduced during the hypotonic era were applied to the analysis of chromosomes from individuals who were mentally retarded or who had other congenital anomalies. In 1959, Lejeune and associates described the first known human trisomy, Down syndrome. In that same year, Ford and associates reported that patients with Turner's syndrome had only one of the two X chromosomes, for a total of 45 chromosomes instead of 46. Rapidly thereafter, additional chromosomal defects were defined, and the cataloguing of human trisomies compatible with life was exhausted. Attention was then turned to structural aberrations and their phenotypic consequences.

Most human chromosomes could not be identified individually before 1970. In that year, Caspersson and associates5 applied fluorescence microscopy to human chromosomes. It was found that chromosomes, when stained with quinacrine, exhibited fluorescent cross bands of different widths. Subsequently, nonfluorescent banding was achieved through a number of different techniques, including various ways of partially denaturing chromosomal DNA. With several of these partial denaturation techniques, subsequent Giemsa staining resulted in reproducible banding patterns that were unique for each chromosome. The technique of banding prophase chromosomes made it possible to define chromosomal segments and break points even more accurately. Through banding techniques, small deletions or duplications of segments of DNA within the chromosome can be precisely identified. This advance made possible the description of a whole new class of chromosomal diseases, the partial trisomy and partial deletion syndromes.

Back to Top
INCIDENCE OF CHROMOSOMAL ABNORMALITIES
The incidence of chromosomal abnormalities among newborn infants has been studied extensively. Pooled data shows that karyotypic abnormalities are found in approximately 5.7/1000 newborns and congenital ocular malformations occur in approximately 6.0/10,000.6–10
Back to Top
CHROMOSOMAL SYNDROMES
The abbreviations and terminology commonly used in describing chromosomal rearrangement are as follows. The letter p is used to represent the short arm of a chromosome and the letter q the long arm. The letters are used after the number of the chromosome under discussion. A plus sign (+) after the letter indicates duplication or partial trisomy for the portion of the arm indicated. A minus sign (-) indicates a partial deletion for a portion of that arm. For example, the 5q+ syndrome is the name used to refer to the clinical entity resulting from any partial duplication of the long arm of chromosome 5. More precise localization along a chromosome arm is provided by a numbering system based on prominent bands beginning at the centromere. Each arm of a chromosome is divided into three to five regions, and these are again subdivided into three or more subunits. Using this system, a single band can be named.

THE TRISOMY SYNDROMES

Trisomy or monosomy for autosomes other than 13, 18, 21, and 22 are almost invariably lethal and are frequently seen in spontaneous abortions.

Trisomy 13 (Patau Syndrome)

Trisomy 13 occurs among newborns at a frequency of 1 in 20,000.11 High maternal age is a factor predisposing to trisomy 13, as it is for other trisomies. About 45% of affected infants die before the age of 1 month with only 5% reaching the age of 3 years, and there are only 5 reports of patients surviving beyond the first decade.12 Wide phenotypic variability in trisomy 13 is the rule and may be secondary to the variable allelic content of the three homologous chromosomes. Partial trisomy for different parts of chromosome 13 has been described. Patients with these partial trisomies have only some of the features of trisomy 13. A clinical chromosomal map has been constructed by matching common clinical features with common regions of chromosome involvement. Clinical features of trisomy 13 include severe mental retardation resulting from holoprosencephaly, cleft lip and palate, and polydactyly (Fig. 1). These patients are often deaf and may have capillary hemangiomas and scalp defects (Fig. 2). The heel is often prominent and the bottom of the foot has the shape of the runners on a rocking chair.13 The ocular features in trisomy 13 range from anophthalmia to microphthalmia. A fleshy pterygium-like corneal opacification may be seen (Fig. 3), and iris and choroidal colobomas are common (Fig. 4). Hypertelorism occurs in almost all cases.14

Fig. 1. Postaxial polydactyly in a patient with trisomy 13. A skin tag is present on the right hand. (Courtesy of Irene Maumenee, MD)

Fig. 2. Scalp defects in a patient with trisomy 13. (Courtesy of Irene Maumenee, MD)

Fig. 3. Central corneal opacity in a patient with trisomy 13.

Fig. 4. Inferior nasal coloboma and a corresponding sector cataract in a patient with trisomy 13, who is probably mosaic. The lens opacity had been stable for 2½ years.

Trisomy 18 (Edward's Syndrome)

Trisomy 18 occurs among newborns at a frequency of 1 in 6000.15 High maternal age is a factor predisposing to trisomy 18, and about 90% of affected infants die before the age of 6 months with only about 5% reaching the age of 1 year. A nearly diagnostic feature for this syndrome is the positioning of the thumb and fingers in a tightly clenched fist. The thumb is flexed inside the fist with the index finger overriding the third digit. Infants with trisomy 18 have a characteristic constellation of clinical features that includes mental retardation, hypertonicity, cardiac defects, low-set malformed ears, and flexion deformities.16 Ocular malformations are commonly found in trisomy 18 patients with hypertelorism described in 87% of patients, and prominent epicanthal folds, microphthalmia/anophthalmia, and ptosis seen in about one third of cases. Other less commonly described findings include globe abnormalities such as corneal opacity, anterior segment abnormalities, cataract, and optic nerve pits and colobomas.17

Trisomy 21 (Down Syndrome)

Down syndrome, the most frequent form of mental retardation caused by a microscopically demonstrable chromosomal aberration, is characterized by well-defined and distinctive phenotypic features and natural history; Down syndrome occurs in 1/800 newborns.18 Trisomy 21 is the most common of all the trisomy syndromes and is the result of aneuploidy involving the smallest human chromosome; 75% of these embryos are aborted spontaneously. Incidence increases with maternal age; the risk of having a liveborn with Down syndrome at maternal age 30 is 1 in 1000 and at maternal age 40 is 9 in 1000.19

The characteristic face of a child with trisomy 21 exhibits epicanthus, oblique palpebral fissures, a protruding tongue, a flat nasal bridge, and low malformed ears. Individuals with Down syndrome have specific major congenital malformations (found in 30% to 40% of patients) such as those involving the heart, particularly the atrioventricular canal, and the gastrointestinal tract. Patients with Down syndrome also have between 10 to 20 times greater risk of leukemia than the chromosomal normal population. In particular, there is an increase of 200 to 400 times the incidence of acute megakaryocytic leukemia. The affected child is mentally retarded and has shortened anteroposterior (AP) skull diameter; short stature; a typical dermatoglyphic pattern that consists of a simian line, distal palmar axial triradius, and a high frequency of ulnar loops; and a life expectancy that is reduced to 71% at 30 years. In the most common form of trisomy 21, there are three free copies of chromosome 21; in about 5% of patients one copy is translocated to another acrocentric chromosome, most often chromosome 14 or 21.20

Eye findings can be extensive and include Brushfield spots, which are circumferentially distributed white spots on the iris. Brushfield spots are a hallmark of Down syndrome and are found in one third of patients. Similar lesions may be present in the chromosomally normal individuals in whom they are referred to as Wofflin nodules. Lens changes are present in the Down syndrome population with approximately 300-fold greater incidence than the general population (11%). Epicanthal folds with short or sparse eyelashes are present in more than 50% of patients. Other eye abnormalities include strabismus (57%), esotropia (90%) greater than exotropia (5%), and frequently associated A or V patterns. Extremes in refractive errors are prevalent in the form of myopia (23%), hyperopia (21%), and astigmatism (22%). Nystagmus has a reported incidence of 29% without specified type. Keratoconus develops in some 15% of Down syndrome patients, and nasolacrimal duct obstruction is present in 15% of patients.21

Trisomy 22

Trisomy 22 is a rare disorder with only 20 reported cases. It is lethal in the immediate postpartum period. Mean maternal age at the time of birth is 30.5 years.22 All of the patients have obvious mental and physical retardation. The most common congenital abnormalities include microcephaly, preauricular skin tags, congenital heart disease, micrognathia, a long philtrum, malformed ears, and a long nose. At least 50% of the patients had cleft palate, malposed thumb and long slender fingers, congenitally dislocated hips, and hypotonia. As many as 30% have hypoplastic or lowset nipples. Cryptorchism was noted in all males. The most common ocular malformations are chorioretinal colobomas and microphthalmia. Other less common features include strabismus and antimongoloid lid slant.23

PARTIAL TRISOMY AND PARTIAL DELETION SYNDROMES

Partial trisomies and monosomies can be viable depending on the size and location of the aberration. These can arise de novo or as a result of unbalanced segregation from a parent carrying a balanced rearrangement. These phenotypes are more variable than those of complete trisomies because the amount of unbalanced genetic material is variable. Nevertheless, several phenotypes emerge as characteristics of extra or missing chromosomal segments in particular regions. Before beginning the discussion of the partial trisomy and partial deletion syndromes, it should be stressed that the exact phenotype associated with a chromosomal deletion or duplication will depend on how much of the chromosome is affected and on which genes are deleted or duplicated. The clinical phenotypes discussed here are useful diagnostically, however, because patients with a deletion or duplication of one arm of a particular chromosome are likely to share certain clinical abnormalities. It is quite possible that two patients, both with a partial duplication or deletion of one arm of a chromosome, share no common clinical features if the affected chromosomal segments do not overlap.

Partial trisomies and partial deletion syndromes with consistent ocular findings are outlined in the following discussion. Partial trisomies or partial deletion syndromes without significant ocular findings or those with isolated reports of eye findings are not included.

3q Plus Syndrome (Cornelia de Lange Phenotype)

Trisomy of a segment of the distal end of chromosome 3 is uncommon. The exact site of duplication lies within the region 3q23 to 3q27 in one of the number 3 chromosomes resulting in a partial trisomy for the distal segment. In most cases, the partial trisomy is the result of a balanced translocation in one parent. Because of these findings, careful banding study should be carried out in all patients with the Cornelia de Lange phenotype. These patients share many of the clinical features described for Cornelia de Lange's syndrome: “carp” mouth, failure to thrive, profound mental retardation, a long philtrum, microcephaly, and congenital heart disease.24 Ocular features include most commonly long eyelashes, hypertelorism, and prominent epicanthal folds.25

4p Plus Syndrome

The clinical features of the 4p+ syndrome are sufficiently consistent to permit clinical diagnosis at birth. In the young child, the face is round, there is a short nose with aplasia the nasal root, and the glabella protrudes over a hypoplastic nasal root. The upper lip is elongated and projects slightly; the chin is pointed and recessed. The ears are low set and usually abnormal. Skeletal deformities of the extremities may be present. Other findings include microcephaly and kyphoscoliosis. Height is usually considerably below normal, and obesity is common. Retardation is severe and may be complicated by seizures.26 Ocular features include iris and choroidal colobomas.27

4p Minus Syndrome

The 4 p- syndrome has an incidence of 1/50,000 live births.31 Children are feeble and hypotonic at birth. Major systemic manifestations include developmental delay (100%), growth retardation (90%), cleft lip and palate, congenital heart disease, and seizures. Simian creases, cryptorchism, and hypospadias are less common.28 Ocular abnormalities play a major role in the phenotypic findings and include strabismus (50%), iris coloboma (30%), and epicanthal folds in addition to hypertelorism, which is a marked feature in patients with the 4p- syndrome (70%).29,30

4q Plus Syndrome

Microcephaly is a consistent feature in the 4q+ syndrome, and the nasal crest continues with a prominent receding forehead. The upper lip is short, and when the mouth is closed both lips protrude in a very distinct manner. Duplication or absence of digits is common. Growth retardation is common. Mental retardation is severe and is frequently complicated by seizures. The ocular features include narrow palpebral fissures, ptosis, epicanthus, and corneal leukomas.31

5p Plus Syndrome

5p+ syndrome is an extremely rare syndrome, which is lethal before 6 months of age. Major manifestations include macrocephaly, low-set posteriorly rotated ears, cleft palate, and short philtrum. Ocular manifestations include primarily hypertelorism and telecanthus.32

5p Minus Syndrome (Cri du Chat Syndrome)

The mewing cat cry of babies with 5p- syndrome, from which the French name for this disorder is derived, becomes less pronounced with increasing age. Patients are unusually chafe as infants, and virtually all affected babies are of low birth weight, exhibit slow growth, and have microcephaly. IQ is severely affected and is usually in the 20 to 30 range. Hypertelorism and a large prominent glabella are present in more than 90% of patients. An antimongoloid lid fissure is present in more than 80% of patients, and epicanthal folds, as well as strabismus, are also common. Aside from the catlike cry and retarded growth, the ocular features are the most consistent findings.33

6p Minus Syndrome

Major malformations in the 6p- syndrome include craniosynostosis (70%) and congenital heart disease (90%), which are hallmarks of the disease. Eye abnormalities occur in about 65% of patients, and microphthalmia, anterior segment dysgenesis, iris colobomas, and prominent epicanthal folds have been reported.34

6q Minus Syndrome

Systemic manifestations of the 6q- syndrome include developmental delay, umbilical hernia, palmar creases, microcephaly, short stature, congenital heart disease, and ectopic kidneys. Prominent ophthalmic findings include downslanting small palpebral fissure (82%) and prominent epicanthal folds (58%).35

7q Plus Syndrome

There are two clinically distinct phenotypes involving duplications of different portions of the long arm of chromosome 7. The first syndrome is caused by deletion of the terminal portion of the long arm and is characterized by low birth weight, growth and mental retardation, cleft palate, micrognathia, a small nose, small palpebral fissures, and hypertelorism. The other 7q+ phenotype is caused by a more proximal duplication in the long arm. The clinical picture for this includes retarded development, hypertelorism, strabismus, and low-set ears. In both, hypertelorism is a prominent ocular feature.27

Trisomy 8 (Warkany Syndrome)

Trisomy 8 is associated with total duplication of one of the medium-sized autosomes. Most of the cases described have been mosaics; that is, they have both normal and abnormal chromosomal cell lines. Most patients are retarded with an IQ that ranges from 10 to 80. Skeletal abnormalities are frequently present including accessory ribs, vertebral defects, absent patella, and a distinctive toe posture with digits two and three having an equal length. Dermatoglyphics show deep furrows in the palms and soles.36 Hypertelorism was noted in 12.5% of patients, and a pronounced antimongoloid lid slant has been observed (33%) (Fig. 5). Less frequent findings related to the eye include ptosis, strabismus, corneal opacity, microphthalmia, coloboma, and heterochromia.36

Fig. 5. Prominent antimongoloid lid slant in a patient with trisomy 8. (Courtesy of Irene Maumenee, MD)

9p Minus Syndrome

In the reported cases of 9p- syndrome, the patients' features are similar enough to allow clinical description. Trigonocephaly, microcephaly, a long upper lip, down-turned corners of the mouth, and a significant protrusion of antihelices are systemic features37 (Fig. 6). The ocular findings include glaucoma, enlarged and highly arched eyebrows, prominent eyes, epicanthal folds, and a mongoloid lid slant.38,39

Fig. 6. This child with the 9p- syndrome has pronounced trigonocephaly, microcephaly, and epicanthal folds. The comers of the mouth are downturned, and mental retardation is significant. (Courtesy of George Donnell, MD, and Omar Alfi, MD, Childrens Hospital of Los Angeles, CA)

9q Plus Syndrome

In the reported cases of 9q+ syndrome, only global delay is a consistent feature. Strabismus, epicanthus, and deep-set eyes are reported ocular findings.40

10p Plus Syndrome

The most common systemic findings associated with this syndrome include hypotonia, frontal bossing, abnormal nares, and clubfoot, all of which occur in greater than 60% of cases.41 Ocular findings are uncommon with this syndrome and include microphthalmia and coloboma.42

10q Plus Syndrome

10q+ syndrome is characterized by a high prominent forehead, an oval face, growth retardation, microcephaly, a small nose with a depressed nasal bridge and anteverted nostrils, a carp-shaped mouth with a prominent upper lip, close-set ears, a short neck, and undescended testicles. Skeletal defects involving the digits of the hands and feet, as well as cardiac defects, are occasionally present. Antimongoloid lid slant, hypertelorism, arched and widespread eyebrows, blepharophimosis, and microphthalmia and ptosis have also been described.43

10q Minus Syndrome

In 10q- syndrome, developmental delay is the rule with associated midfacial hypoplasia, prominent receding forehead, and hypotonia. Various dermatologic lesions are associated with this syndrome, although lesions frequently do not present until puberty. As with many partial deletion syndromes, hypertelorism and midfacial hypoplasia are prevalent ocular findings.44

11p Plus Syndrome

The developmental abnormalities in the few cases of the 11p+ syndrome that have been described are due primarily to disturbance of craniofacial development. Systemic findings include a high, prominent forehead with frontal upsweep of hair, wide glabella, a broad flat nasal bridge, and cleft lip or palate. Psychomotor retardation and hypotonia are the rule for this disorder. Ocular findings include supraorbital ridges antimongoloid palpebral fissures, as well as strabismus and nystagmus.45

11p Minus Syndrome

Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation (WAGR) syndrome is associated with a deletion in the short arm of chromosome 11 involving PAX6 at 11p11.3.46 Systemic manifestations of WAGR syndrome include hypotonia, midline brain abnormalities, and hearing deficits. The heterogeneity in the aniridia deletion syndrome is secondary to small variations in the amount of genetic material deleted in patients. Both males and females are affected with the 11p- syndrome, and nearly all cases have been sporadic. Gonadoblastoma with aniridia has been reported in children with the 11p- syndrome. The fact that dominantly inherited aniridia generally is not associated with Wilms' tumor or other abnormalities is not surprising, because linkage studies have shown that the locus for the mild familial form of aniridia is on chromosome 1.47 Wilms' tumor is usually associated with the sporadic form of aniridia. Aniridia is the most consistent eye finding, although others including cataracts, foveal hypoplasia, nystagmus, and glaucoma are also prevalent.48

11q Minus Syndrome (Jacobsen Syndrome)

This uncommon disorder has an incidence of less than 1 in 100,000 births.49 Developmental delay and trigonocephaly are the most common systemic abnormalities occurring in greater than 95% of patients afflicted with the syndrome.50 Micrognathia, carp-shaped mouth, cardiac abnormalities, and skeletal abnormalities are also common. Commonly reported ocular findings include hypertelorism, ptosis, and prominent epicanthal folds.51,52

13q Plus Syndromes

When the entire chromosome is duplicated, the well-described trisomy 13 syndrome occurs. There are at least two groups of patients with different clinical pictures who show partial duplication of chromosome 13.53 In the first group, the trisomy consists of duplication of the proximal one third to one half of the long arm of chromosome 13. The clinical features are nonspecific and include psychomotor retardation, microcephaly, low-set ears, microsomia, micrognathia, and clinodactyly with little ocular involvement. When the distal one third to two thirds of the long arm is present in triplicate, many of the features of complete trisomy 13 are present. In this group, unlike in the complete trisomy syndrome, deafness, eye malformations, cleft palate, harelip, and heart defects are not observed.

13q Minus Syndrome

Chromosome 13 is of particular interest to ophthalmologists because when a portion of the long arm is deleted, retinoblastoma may occur. A review of patients with partial deletion of chromosome 13 showed that the presence of hypoplastic thumbs indicates involvement of the distal segment of the long arm of chromosome 13. Other clinical features of the distal segment deletion included mental retardation, microcephaly, and hypertelorism in approximately 85% of cases.54 Additional findings included a protruding maxilla, epicanthal folds, renal abnormalities, heart disease, metacarpal fusion, aplastic thumbs, microphthalmia, coloboma, and large low-set ears. A number of the patients with 13q minus syndrome had retinoblastoma subsequently found to be associated with a deletion that included a band in the proximal portion of the long arm.55 Although most of the children whose retinoblastoma is associated with the deletion of the long arm of chromosome 13 have other congenital abnormalities, some appear to be normal except for a mild developmental delay. The severity of the associated abnormalities depends on the amount of chromosomal material lost (Fig. 7). Among patients with retinoblastoma, approximately 3% have a chromosome 13 deletion. Because both unilateral and bilateral retinoblastoma have been observed in patients with deletion of chromosome 13, it may be virtually impossible to determine clinically whether a chromosomal deletion might be present. For these reasons, when observing a new patient with retinoblastoma, ophthalmologists should search diligently for evidence of other developmental abnormalities. Even in the absence of any systemic developmental defects, however, one cannot be certain that the chromosome deletion does not exist.56,57

Fig. 7. Unilateral congenital ptosis and antimongoloid lid fissures (outer canthus lower than inner canthus) in a child with the 18p- syndrome. (Courtesy of Irene Maumenee, MD)

14q Plus (Proximal and Distal) Syndrome

The 14q plus (distal) syndrome is one of two partial trisomy syndromes involving the long arm of chromosome 14. Mental retardation is severe. Other abnormalities include microcephaly, a high forehead, low-set ears, a highly arched or cleft palate, a protruding upper lip, camptodactyly, micrognathia, congenital heart disease, and 12th rib hypoplasia.58 Ocular features include epicanthal folds and antimongoloid slant. Prominent features of the 14q plus (proximal) syndrome include motor and mental retardation, seizures, hypotonia, low anterior hairline, low-set ears, a prominent philtrum, long tapered fingers, kyphosis, and a short neck. Ocular features include antimongoloid lid slant, small palpebral fissures, microphthalmia, strabismus, and ptosis.58

15q Minus Syndrome

The Prader-Willi syndrome and Angelman syndrome are associated with deletions of the long arm of chromosome 15. Systemic findings in Prader-Willi syndrome include hypotonia, developmental delay, and small extremities, as well as hypogonadism and cryptorchidism. Angelman syndrome has the systemic findings of Prader-Willi syndrome with more significant developmental delay including seizures.59 Ocular findings are not a large part of these syndromes.

16p Minus Syndrome

This rare deletion syndrome is most commonly associated with developmental delay and alpha thalassemia. Other systemic findings include capillary hemangiomas and midfacial hypoplasia. As with many other deletion syndromes, hypertelorism and prominent epicanthal folds are common eye findings.60

17p Minus Syndrome (Smith-Magenis Syndrome)

The most characteristic physical findings of Smith-Magenis syndrome include short stature, midfacial hypoplasia, and brachydactyly, as well as developmental delay and profound mental retardation.61 Ocular findings are inconsistent and include most commonly prominent epicanthal folds, with scattered reports of Brushfield type spots and high myopia.62

18p Minus Syndrome

Clinical features of the 18p- syndrome include mental retardation, growth delay, and abnormal ears (see Fig. 7). Myopia, antimongoloid lid fissures, cataract, and uveal colobomas are reported to be present27 (Fig. 8).

Fig. 8. Typical iris coloboma in a patient with the 18p- syndrome (same patient shown in Figure 7). (Courtesy of Irene Maumenee, MD)

18q Minus Syndrome (DeGrouchy Syndrome)

DeGrouchy syndrome is perhaps the most common of all the partial trisomy and partial deletion syndromes. More than 100 cases have been studied and reported. Systemic features include low birth weight, profound mental retardation, developmental delay, short stature, microcephaly, midface dysplasia, carp-shaped mouth, widely spaced nipples, long tapering fingertips, and irregular external ears.63 Conspicuous skin dimples are present over the sides of the patella and the back of the hands. Ocular abnormalities include nystagmus (30%) and bilateral optic atrophy (29%), as well as strabismus, glaucoma, pigmentary retinal degeneration, and ocular colobomas.27,64

20p Plus Syndrome

Patients with partial trisomy of the short arm of chromosome 20 are almost always thought to be normal at birth. The development of prominent cheeks and a short chin characterizes the facies. Telecanthus is present in 50% of cases, and there is a mongoloid like lid slant in 75% of cases.45

20p Minus Syndrome

Prominent physical findings in this condition include triangular chin with prominent forehead and long straight nose. Systemic associations are cholestasis, hemivertebrae, and pulmonary tree stenosis. Ocular features such as hypertelorism and deep-set eyes, as well as anterior segment digenesis including posterior embryotoxon and iris adhesions, are common.45 Alagille syndrome is believed to be a variant of 20p minus syndrome involving a single gene site, 20p11.23–12.65

22q minus Syndrome (DiGeorge Syndrome)

DiGeorge syndrome occurs in 1/4000 live births. The hallmark systemic findings include conotruncal heart anomalies, hypoplastic thymus, and variable developmental delays. Ophthalmic findings have been well studied and include posterior embryotoxon (69%), tortuous retinal vessels (58%), and upper lid hooding (41%) among others.66

The Cat-Eye Syndrome (Supernumerary Chromosome 22q)

The cat-eye syndrome is associated with a supernumerary marker derived from chromosome 22q. However, in many of the reported cases, the marker is present in only a portion of the patient's cells. Because mosaicism is sometimes transmitted through generations, Mendelian factors may be important in its causation.67 Although variability of clinical features is enormous, the usual triad necessary for the diagnosis of the cat-eye syndrome is made up of uveal coloboma, an imperforate anus, and renal malformations. The disorder was named the cat-eye syndrome because of the characteristic vertical iris colobomas that are frequently present. Additional systemic findings are preauricular skin pits, fistulas, or tags and congenital heart disease.68 Although the disorder has been described with a normal karyotype, the usual finding is the presence of a small, extra submetacentric chromosome. Variable features of the syndrome may be present in other family members. The exact nature of the extra fragment in all cases is not agreed on, and it is clear that the extra fragment is mitotically unstable and may retard cell division during the critical period of embryogenesis when the fetal fissure would normally be closing.

Several reports suggest that the coloboma, which is a consistent feature of trisomy 13, might be contributed to the cat-eye syndrome by the portion of chromosome 13 that is near the centromere. That portion of the cat-eye syndrome that is similar to trisomy 22 might be contributed by the portion of chromosome 22 near the centromere. A balanced translocation carrier state may explain those families in which generations seem to be skipped.69

The minimal criteria for making the diagnosis of cat-eye syndrome are as follows: (1) combination of two major features, coloboma and anal atresia, with or without associated abnormalities; (2) combination of one major feature, coloboma or anal atresia, with at least one of the most frequently associated minor anomalies, such as preauricular skin tags or renal anomalies; (3) the presence of one major feature plus several less frequently found abnormalities, such as antimongoloid lid slants, congenital heart disease, and skeletal anomalies; and (4) a combination of five or more minor specific features. There is some overlap in clinical features between trisomy 22 and the cat-eye syndrome.70

Back to Top
HUMAN CHROMOSOME MAPPING: CLINICAL IMPLICATIONS
Decoding the DNA that constitutes the human genome has been widely anticipated for the contribution that it will make toward understanding human evolution, the causation of disease, and the relationship between the environment and heredity in defining the human condition. Now that the Human Genome Project is essentially completed with the reporting of the 3.2 billion base pair sequences of the human genome, the true challenge becomes the interpretation and use of this vast amount of genetic data. As recently as 15 years ago, the genes for three major genetic disorder: retinoblastoma, chronic granulomatous disease, and Duchenne muscular dystrophy were reported. This initiated a new phase in the application of the molecular genetics to the dissection of human inherited diseases. In all three cases, researchers tracked the genes in question by cytogenetic clues, rather than by insights into function of the protein or positional cloning. With the completion of the Human Genome Project, genetics is now embarking on a new chapter, one that will have profound changes in the way information for positional cloning is gathered, analyzed and used.

Ophthalmologic disorders have played prominent roles in the mapping story. Zonular pulverulent cataracts were shown to be linked to the first human gene mapped, the Duffy blood group. Because of that linkage, the gene for this type of cataract was able to be mapped to chromosome 1. Evidence that the locus for dominant retinoblastoma was on chromosome 13, closely linked to the locus for esterase D in chromosomal region 13q14, was also reported. Mapping of ocular disorders and the delineation of closely linked enzyme or DNA polymorphisms could provide a most productive pathway to improved genetic counseling and prenatal diagnosis in ocular disorders. Many dominant eye diseases may potentially be mapped. It is possible that a detailed map of the chromosomes could be a valuable resource for gene repair and replacement in ocular conditions.

As welcome as these advances are, there is a major leap between identifying genes for rare disorders and contributing to and treating the medical condition. It has been predicted that complete sequencing in the human genome would open up new strategies for human biologic research and would have a major impact on medicine, public health, and society. Effects of that biomedical research are already being sought, and the assembly of the human genome sequence is the first step on a long journey towards understanding the rule of the genome project in ophthalmology.

Back to Top
REFERENCES

1. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001;291:1304

2. Lewandowski RC Jr, Yunis JJ. Phenotypic mapping in man. In New Chromosomal Syndromes. New York: Academic Press, 1977:369–394

3. Howard RO, Bove J, Beluchat CH et al. The eyes of embryos with chromosome abnormalities. Am J Ophthalmol 1974;78:167

4. Tjio JH, Levan A. The chromosome number of man. Hereditas 1956;42:1

5. Caspersson T, Zech L, Johansson C et al. Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma 1970;30:215

6. Sergovich F, Valentine GH, Chen A et al. Chromosome aberrations in 2159 consecutive newborn babies. N Engl J Med 1969;280:851

7. Lubs HA, Ruddle FH. Applications of quantitative karyo-type to chromosome variation in 4400 consecutive newborns. In Jacobs PA, Price WH, Law P (eds). Human Population Cytogenics. London: Edinburgh University Press, 1970:119–142

8. Friedrich V, Nielson J. Chromosome studies in 5049 consecutive newborn children. Clin Genet 1973;4:333

9. Jacobs PA, Melville M, Ratcliffe S et al. A cytogenic survey of 11,680 newborn infants. Ann Hum Genet 1973-1974;37:369

10. Stoll C, Alembiky, Dott B et al. Epidemiology of congenital eye malformations in 131,760 consecutive births. Ophthalmic Paediatr Genet 1992;13:179

11. Goldstein H, Nielsen KG. Rates and survival of individuals with trisomy 13 and 18. Clin Genet 1988;34:366

12. Zoll B, Wolf J, Lensing-Hebben D et al. Trisomy 13 with an 11 year survival. Clin Genet 1993;43:46

13. Wyllie JP, Wright MJ, Burn J et al. Natural history of trisomy 13. Arch Dis Child 1994;7:343

14. Therman E. Human Chromosomes. New York: Springer-Verlag, 1980.

15. Fisher JM, Harvey JF, Linderbaum RH. Molecular studies of trisomy 18. Am J Hum Genet 1977;35:241

16. Root S, Carey JC. Survival in trisomy 18. Am J Med Genet 1994;49:170

17. Ginsberg M, Perrin E, Sueoka WT. Ocular manifestations of trisomy 18. Am J Ophthalmol 1988;66:59

18. Hook EG. Epidemiology of Down syndrome. In Pueschel S, Rynders JE (eds). Down syndrome. Advances in Biomedicine and the Behavioral Sciences. Cambridge: Ware Press, 1982:11

19. Penrose LS. The relative effects of paternal and maternal age in mongolism. J Genet 1933;27:219

20. Korenberg J, Kawashima H, Pulst S et al. Molecular definition of the region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 1990;47:236

21. Caputo AR, Wagner RS, Reynolds DR et al. Down syndrome: Clinical review of ocular features. Clin Pediatr 1989;28:355

22. Hsu LYF, Hirschhorn K. The trisomy 22 syndrome and the cat eye syndrome. In Yunis JJ (ed): New Chromosomal Syndromes. New York: Academic Press, 1977.

23. Antle CM, Pantzar JT, White VA. The ocular pathology of trisomy 22: Report of two cases and review. J Pediatr Ophthalmol Strabismus 1990;27:310

24. Sciorra LJ, Bahng K, Lee M. Trisomy in the distal end of the long arm of chromosome 3. Am J Dis Child 1979;133:727

25. Rizzu P, Hadad BR, Vallcorba I et al. Delineation of a duplication map of chromosome 3q: A new case confirms the exclusion of 3q25-q26.2 from the duplication 3q syndrome critical region. Am J Med Genet 1997;68:428

26. Wilson MG, Toroner JW, Coffin GS et al. Inherited pericentric inversion of chromosome number 4. Am J Hum Genet 1970;22:679

27. Jay M. The eye in Chromosome Duplications and Deficiencies. New York: Marcel Dekker, 1977.

28. Guthrie RD, Aase JM, Asprer AC et al. The 4p- syndrome. Am J Dis Child 1971;122:421

29. Estabrooks LL, Lamb AN, Aylsworth AS et al. Molecular characterisation of chromosome 4p deletions resulting in Wolf-Hirschhorn syndrome. J Med Genet 1994;31:103

30. Johnson VP, Mulder RD, Hosen R. The Wolf-Hirschhorn (4p-) syndrome. J Med Genet 1976;10:104

31. Dutrillaux B, Laurent C, Forabosco A et al. La trisomie 4q partialle. A propos de trois obersvations. Ann Genet 1975;18:21

32. Leichtman LG, Werner A, Bass WT et al. Apparent Opitz BBBG syndrome a partial duplication of 5p. Am J Med Genet 1991;40:173

33. Howard RO. Ocular abnormalities in the cri-du-chat syndrome: Study of seven patients. Am J Ophthalmol 1972;73:949

34. Palmer CG, Bader P, Slovak ML et al. Partial deletion of chromosome 6p: Delineation of the syndrome. Am J Med Genet 1991;39:155

35. Gershoni-Baruch R, Mandel H, Bare EL et al. Interstitial deletion (6)q13q15. Am J Med Genet 1996;62:345

36. Riccardi VM. Trisomy 8: An international study of 70 patients. Birth Defects: Orig Art Ser 1977;13:171

37. Cantu ES, Eicher DJ, Pai GS et al. Mosaic vs. nonmosaic trisomy 9: Report of a liveborn infant evaluated by fluorescein in situ hybridization and review of the literature. Am J Med Genet 1996;62:330

38. Alfi OS, Donnel GN, Crandall BF et al. Deletion of the short arm of chromosome no. 9(46, 9p-): A new deletion syndrome. Ann Genet 1973;16:17

39. Verbraak FD, Pogany K, Pilon J et al. Congenital glaucoma in a child with partial 1q duplication and 9p deletion. Ophthalmic Paediatr Genet 1992;13:165

40. Stalker HJ, Ayme S, Delneste D et al. Duplication of 9q12-q33: A case report and implications for the dup(9q) syndrome. Am J Hum Genet 1993;45:456

41. Clement SJ, Leppig KA, Jarvik GP et al. Trisomy 10p+: Report of an unusual mechanism of formation and critical evaluation of the clinical phenotype. Am J Med Genet 1996;65:197

42. Hoo JJ, Chao M, Szego K et al. Four new cases of inverted terminal duplication: A modified hypothesis of mechanism of origin. Am J Med Genet 1995;58:299

43. Prosperi L, Bernasconi S, Forabosco A. Ocular phenotype in partial 10q+. Ophthalmolgica 1978;175:269

44. Arch EM, Goodman BK, Van Wesep RA et al. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 1997;71:489

45. Frank U. Abnormalities of chromosomes 11 and 20. In Yunis JJ (ed). Chromosomes in Biology and Medicine. New York: Academic Press, 1977:246–271

46. Riccardi VM, Sujansjy E, Smith AC et al. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978;61:604

47. Warburg M, Mikkelsen M, Anderson SR et al. Aniridia and interstitial deletion of the short arm of chromosome 11. Metab Pediatr Ophthalmol 1980;4:97

48. Hittner HM, Francke U. Aniridia caused by a heritable chromosome 11 deletion. Ophthalmology 1979;86:1173

49. Penny LA, Dell'Aquila M, Jones MC et al. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet 1995;56:676

50. Cassidy SB, Heller RM, Kilroy AW et al. Trigonocephaly and the 11q-syndrome. Ann Genet 1997;20:67

51. Obregon MG, Mingarelli R, Digilio MD et al. Deletion 11q23-ater (Jacobsen syndrome): Report of three new patients. Ann Genet 1992;35:208

52. Hertz JM, Tommerup N, Sorensen FB et al. Partial deletion of 11q: Report of a case with a large terminal deletion 11q21-qter without loss of telomeric sequences and review of the literature. Clin Genet 1995;47:231

53. Niebuhr E. Partial trisomies and deletions of chromosome 13. In Yunis JJ (ed): Chromosomes in Biology and Medicine. New York: Academic Press, 1977:273–299

54. Brown S, Gersen S, Anyane-Yeboa K, Warburton D. Preliminary definition of a “critical region” of chromosome 13 in q32: Report of 14 cases with 13q deletions and review of the literature. Am J Hum Genet 1993;45:52

55. Ganesh A, Kenue R, Mitra S. Retinoblastoma and the 13q deletion syndrome. J Pediatr Ophthalmol Strabismus 2001;38:4:247

56. Mills MD, Windle JJ, Albert DM. Retinoblastoma in transgenic mice: Models of hereditary retinoblastoma. Surv Ophthalmol 1999;43:508

57. Brown S, Russo J, Chitayat D et al. The 13q- syndrome: The molecular definition of a critical deletion region in a band 13q32. Am J Hum Genet 1995;57:859

58. Wyandt HE, Magenis RE, Hecht F. Abnormal chromosomes 14 and 15 in abortions, syndromes and malignancies. In Yunis JJ (ed). Chromosomes in Biology and Medicine. New York: Academic Press, 1977:301–338

59. Carrozzo R, Rossi E, Christian SL et al. Inter and intrachromosomal rearrangements are both involved in the origin of 15q11-q13 deletions in the Prader-Willi syndrome. Am J Hum Genet 1997;61:228

60. Lindor NM, Valdes MG, Wick M et al. De novo 16 p deletion. ATR-16 Syndrome. Am J Med Genet 1997;72:451–454

61. Finucane BM, Kurtz MB, Babu VR et al. Mosaicism for deletion 17p11.2 in a boy with Smith-Magenis syndrome. Am J Genet 1993;45:447

62. Juyal RC, Kuwano A, Kondo I et al. Mosaicism for del(17) (p11.2p11.2) underlying the Smith-Magenis syndrome. Am J Med Genet 1996;66:193

63. DeGrouchy J. The 18p-, 18q- and 18r syndromes. In Bergsma D (ed). Part V, Phenotypic Aspects of Chromosomal Aberrations. Birth Defects Original Article Series Vol 5, No 5. New York: The National Foundation March of Dimes, 1969:74

64. Wilson MG, Towner JW, Forsman I et al. Syndromes associated with deletion of the long arm of chromosome 18[del(18q)]. Am J Med Genet 1979;3:155

65. Krantz ID, Rand EB, Gennin A et al. Deletions of 20p12 in Alagille syndrome: Frequency and molecular characterization. Am J Med Genet 1997;70:80

66. Forbes, BJ, Edmund JC. Personal observation, 2000.

67. Franklin RC, Parslow MI. The cat eye syndrome. Review and tow further cases occurring in female siblings with normal chromosomes. Acta Paediatr Scan 1972;61:581

68. Crolla JA, Howard P, Mitchell C et al. A molecular and FISH approach to determine karyotype and phenotype correlations in six patients with supernumerary marker(22) chromosomes. Am J Med Genet 1997;72:440

69. Weleber RG, Walknowska J, Peakman D. Cytogenic investigation of cat eye syndrome. Am J Med Genet 1977;84:477

70. Kalapakian B, Choy AE, Sparkes RS et al. Duane syndrome associated with features of the cat eye syndrome and mosaicism for a supernumerary chromosome probably derived from number 22. J Pediatr Ophthalmol Strabismus 1988;25:293

Back to Top